Latest news and events

Are you going to Anaheim for Natural Products Expo West this year?

Get ready for the Sports & Active Nutrition Summit USA

New study gains global attention: Can a daily capsule make you biologically younger? A major European study shows that omega-3 alone can reduce epigenetic age.

The $2 trillion global wellness market is undergoing significant transformations driven by the evolving preferences of millennials and Gen Z.

Fish oils are good sources for dietary intake of omega-3 fatty acids EPA and DHA, but does the fatty acid form matter?

Epax launches first commercially available VLC-PUFA product

EPAX® Evolve 05 is a concentrated marine Omega-3 formula containing lipids that go beyond long-chain EPA and DHA. Epax has developed technology to produce a concentrated oil abundant in very long chain polyunsaturated fatty acids (VLC-PUFA),which play essential roles in various physiological functions within the body. Here, we elaborate on the significance of these fatty acids in relation to longevity, tears, vision and male fertility.

EPAX 4020 TGN has been shown in a pre-clinical study to help improve post-injury muscle recovery and maintain neuromuscular performance in aging, a pilot study has found.

Epax has achieved a significant milestone with their scientific paper on VLC-fatty acids being nominated by the British Journal of Nutrition for the BJN Paper of the Year 2024.

The $10 million investment in the facility in Aalesund, Norway includes the construction of a new synthesis plant.

Epax® has always been dependent on the sea and, as a result, there is an ingrained respect for the life it holds and the many livelihoods its waters provide. The history being closely tied to the sea has created an unmatched passion for all things marine for us.

Healthy aging has become increasingly important as many societies face a demographic shift to an elderly population. Read more about how Omega-3 may aid as one ages

Discover the science behind EPAX® Omega 3-9-11, a breakthrough marine oil combining Omegas 3, 9, and 11 for advanced health benefits. Developed using Epax’s pioneering distillation technology, this unique blend harnesses the power of North Atlantic fish to deliver high-purity LC-PUFA and LC-MUFA. Backed by research, EPAX® Omega 3-9-11 supports heart, skin, and metabolic health, offering a new frontier in marine lipid nutrition.

Films will convince us that depression after failed love can be cured by a bucket of ice cream. But can food and nutrition really comfort and help us through difficult times? The answer is yes, although I´m sorry to say that chocolates and ice cream are just plasters on a sore.

Reasons for taking omega-3 for cardiovascular health were given a solid boost last month with the publication in Mayo Clinic Proceedings of a comprehensive study by O´Keefe of over 117,000 individuals looking at DHA blood levels and mortality.

Epax has launched a full-spectrum oil offering a unique combination of Omegas 3, 9 and 11, with particular potential for skin health supplements.

This certification is not only proof of our dedication to customer safety and trust but also recognition of our team working tirelessly to meet and exceed the industry's highest standards

Geir Frode was honoured as a GOED Member Extraordinaire for all the contributions he’s made in the technical field for the Omega-3 industry at the 2024 GOED Exchange in Athens, Greece, in January

Understanding the average omega-3 index is important from a global health perspective, and the map published in 2016 has now been updated!

GOED has launched CS-GOED Nutraceutical Oils Laboratory Proficiency Program (LPP) to enable laboratories to assess their proficiency in quantifying EPA and DHA in omega-3 oils.

The black box-protected technology is the result of years of research and development

New independent research highlights the impact of high-DHA Epax oil on testosterone levels in overweight and obese men.

Dr. Morten Bryhn, scientific adviser at Epax, discusses how a health diet and supplementation can help fight dementia.

Epax reduced CO₂ emissions by switching by-product transport to sea and producing renewable biofuel.

As part of an increased focus on organoleptic values, Epax has been an active participant in and contributor to the research project ‘QOMEGA-3 – Sensory Industry Standard for Marine Oils’, a project run by Norwegian research service company Møreforsking, funded by the Norwegian Research Fund (FHF).

At Epax, we have a long and proud tradition of supporting the scientific community with study medication. We do this to help develop new and independent science on the wonderful effects of Omega-3.

The members of GOED recently voted to reduce the maximum limit on lead from 0.1 to 0.05 mg/kg in the GOED Voluntary Monograph.